Sudarshan Chemical Industries
Manufacturing · 1 quarter tracked · source-linked performance and management context.
Latest revenue
₹2,103 Cr
verified financial record
Quarters tracked
1
source records in the directory
Delivery assessment
Unscored
No scored management commitments are present yet.
Call date
2026-02-10
latest available source date
Signal trajectory
1 actual quarterCurrent read
Unscored
No scored management commitments are present yet.
Latest source read
What changed this quarter?
Sudarshan Chemical reported a tough Q3 FY26, with the acquired Heubach/Clariant business posting a €38 million EBITDA loss, driven by customer destocking and weak demand in Europe and North America. Legacy Sudarshan revenues were flattish. Management highlighted that customer trust has been rebuilt and buying has resumed in January/February, expecting a €9-10 million business EBITDA in Q4. However, a planned inventory reduction of €30-40 million over three quarters will temporarily depress reported EBITDA by €9-12 million due to overhead absorption. The long-term target of €90-100 million EBITDA remains intact, but near-term risks include slower-than-expected demand recovery and execution challenges in cost synergies.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Negative
Revenue
₹2,103 Cr
Source date
2026-02-10
Across the record
Quarter history.
History modules